Literature DB >> 11840275

Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.

N Grardel, C Roumier, V Soenen, J L Lai, I Plantier, C Gheveart, A Cosson, P Fenaux, C Preudhomme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11840275     DOI： 10.1038/sj.leu.2402332

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

Authors:  Yasuhiko Kamikubo; Ling Zhao; Mark Wunderlich; Takeshi Corpora; R Katherine Hyde; Thomas A Paul; Mondira Kundu; Lisa Garrett; Sheila Compton; Gang Huang; Linda Wolff; Yoshiaki Ito; John Bushweller; James C Mulloy; P Paul Liu
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis.

Authors:  ShriHari S Kadkol; Annette Bruno; Carol Dodge; Valerie Lindgren; Farhad Ravandi
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

3.  Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.

Authors:  Wenyi Zhang; Hainan Wang; Peilei Zhang; Hongliang Li; Xiaoli Ma; Hongxing Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-29       Impact factor: 2.590

Review 4.  NF-κB: A Druggable Target in Acute Myeloid Leukemia.

Authors:  Barbara Di Francesco; Daniela Verzella; Daria Capece; Davide Vecchiotti; Mauro Di Vito Nolfi; Irene Flati; Jessica Cornice; Monica Di Padova; Adriano Angelucci; Edoardo Alesse; Francesca Zazzeroni
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.